3D Silk Fibroin Scaffold for Long-Term Mitochondrial Toxicity Screening

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing 2D cell culture models are inadequate for assessing chronic mitochondrial toxicity, and current 3D spheroid systems are limited by small cell numbers, high cost, and short testing durations, failing to provide a suitable long-term culture for drug toxicity assessment.

Innovation Solution

A 3D scaffold made of electrospun silk fibroin with a crosslinked porous matrix supports stem cells, allowing for a stable mitochondrial DNA presence for at least 6 weeks, and includes a dynamic culture system with macrophages, endothelial, and stromal cells to test drug toxicity effectively.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If 2D cell culture models are used for toxicity testing, then the testing process is simple and cost-effective, but the models are inadequate for assessing chronic mitochondrial toxicity

Engineering Contradiction:

Improvesimplicity of testing processVSAvoidaccuracy of mitochondrial toxicity assessment

Core Design Contradiction:

Ease of manufactureVSReliability

Solution Approach 1:

The patent transitions from 2D cell culture models to 3D spheroid models, adding a spatial dimension that better mimics in vivo tissue architecture. This dimensional change enables more accurate assessment of chronic mitochondrial toxicity while maintaining relative simplicity in the testing approach.

Inventive Principle:

Principle #17Another dimension (Dimensionality change)

2Reliability

If 3D spheroid systems are used for long-term culture, then the mitochondrial toxicity assessment accuracy is improved, but the cell numbers are limited and testing duration is short

Engineering Contradiction:

Improveaccuracy of mitochondrial toxicity assessmentVSAvoidcell numbers and testing duration

Core Design Contradiction:

ReliabilityVSProductivity

Solution Approach 1:

The patent employs porous scaffolds with optimized pore sizes to support 3D cell culture. The porous structure provides adequate nutrient diffusion and waste removal, enabling long-term culture of sufficient cell numbers while maintaining the reliability of mitochondrial toxicity assessment.

Inventive Principle:

Principle #31Porous materials

3Reliability

If long-term 3D culture is implemented for chronic toxicity testing, then the testing accuracy is improved, but the cost and complexity increase significantly

Engineering Contradiction:

Improveaccuracy of chronic toxicity testingVSAvoidcomplexity of culture system

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent develops a universal 3D culture platform using porous scaffolds that can support multiple cell types and be used for various toxicity assessments. This multi-functional system reduces overall complexity by providing a single platform solution rather than requiring separate specialized systems for different testing scenarios.

Inventive Principle:

Principle #6Universality (Multi-functionality)

Data Source

PatentUS20260035670A1In vitro construct useful for drug toxicity screening

Publication Date: 2026.02.05 WAKE FOREST UNIVERSITY HEALTH SCIENCES INC

AI summary

An in vitro construct useful for toxicity testing is provided, comprising: a three-dimensional (3D) scaffold comprising silk fibroin and having a crosslinked porous matrix; and stem cells adherent to the 3D scaffold. In some embodiments, the stem cells adherent to the 3D scaffold maintain stable mitochondrial DNA in long term culture. In some embodiments, the stem cells are urine stem cells.